Richard (rick) D Murdock

Biography

Rick is a seasoned entrepreneur with over three decades of successful executive management experience. He currently serves as consultant, advisor and director to Teneobio, Inc. a next generation biotechnology company. He has served as a Director for a number of Life Science companies. He served as Chairman, President and CEO and Director of SangStat Medical, a publicly traded, fully profitable, biotech company which was acquired by Genzyme Corporation in 2004. Prior to that he was the President and CEO and Director of Kyphon, Inc. a very successful orthopedic spine medical device company which was later acquired by Medtronic Corp. Prior to Kyphon Rick was the President, CEO and Director of CellPro Inc. one of the first publicly traded biotech companies to successfully develop products for stem cell transplantation. He has also held key management positions in a number of US and multinational healthcare companies including: Haemonetics Corporation, Baxter Healthcare-Fenwal Division, HemaScience Laboratories, where he was a founder (acquired by Baxter Healthcare), and Cytogen Corporation. His career began with a successful run in field sales and marketing at Ortho Diagnostics (a Johnson & Johnson Company). Mr. Murdock received his B.S. in Zoology from the University of California at Berkeley. He is an author of the book, “Patient Number One,” Crown Publishing, 2000. Rick is a seasoned entrepreneur with over three decades of successful executive management experience. He currently serves as consultant, advisor and director to Teneobio, Inc. a next generation biotechnology company. He has served as a Director for a number of Life Science companies. He served as Chairman, President and CEO and Director of SangStat Medical, a publicly traded, fully profitable, biotech company which was acquired by Genzyme Corporation in 2004. Prior to that he was the President and CEO and Director of Kyphon, Inc. a very successful orthopedic spine medical device company which was later acquired by Medtronic Corp. Prior to Kyphon Rick was the President, CEO and Director of CellPro Inc. one of the first publicly traded biotech companies to successfully develop products for stem cell transplantation. He has also held key management positions in a number of US and multinational healthcare companies including: Haemonetics Corporation, Baxter Healthcare-Fenwal Division, HemaScience Laboratories, where he was a founder (acquired by Baxter Healthcare), and Cytogen Corporation. His career began with a successful run in field sales and marketing at Ortho Diagnostics (a Johnson & Johnson Company). Mr. Murdock received his B.S. in Zoology from the University of California at Berkeley. He is an author of the book, “Patient Number One,” Crown Publishing, 2000.

Research Interest

Business and Management